Solvotrin irons out global mineral deficiencies
The company has since grown rapidly, doubling from seven to 15 employees in the past year, and will expand to 20 staff members by early next year
Irish pharma company Solvotrin Therapeutics is seeking €500,000 in EIIS funding as it ramps up sales of its Active Iron supplements into international markets.
Former Ernst & Young Entrepreneur of the Year finalist Pat O’Flynn, along with pharmaceutical chemist Professor John Gilmer and clinician, entrepreneur and expert adviser to the Irish Medicines Board Dr Mark Ledwidge, established Solvotrin in 2010 as a spin-out from Trinity College Dublin and launched their first product range last year....
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Construction app helping put site safety first
LexTech.ie keeps construction firms on the right side of the law by digitising and automating health and safety
Paving the way to better roads
Topcon’s SmoothRide™ technology is meeting the ongoing challenges of making surfaces and roads built to last
Interactive maps point the way to new broadband networks
High-tech mapping backed by cloud services is driving Ireland’s next step in broadband connectivity
Awards to highlight how firms have adapted to pandemic
The flagship awards scheme run by Deloitte Private and Bank of Ireland is unique in its approach to recognising indigenous companies whose ambition plays such a crucial role in supporting the economy and sustaining employment
